重塑骨髓微环境——靶向 MPN 中促炎贡献物的建议。
Remodeling the Bone Marrow Microenvironment - A Proposal for Targeting Pro-inflammatory Contributors in MPN.
机构信息
Division of Hematology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, United States.
出版信息
Front Immunol. 2020 Aug 31;11:2093. doi: 10.3389/fimmu.2020.02093. eCollection 2020.
Abstract
Philadelphia-negative myeloproliferative neoplasms (MPN) are malignant bone marrow (BM) disorders, typically arising from a single somatically mutated hematopoietic stem cell. The most commonly mutated genes, , , and lead to constitutively active JAK-STAT signaling. Common clinical features include myeloproliferation, splenomegaly and constitutional symptoms. This review covers the contributions of cellular components of MPN pathology (e.g., monocytes, megakaryocytes, and mesenchymal stromal cells) as well as cytokines and soluble mediators to the development of myelofibrosis (MF) and highlights recent therapeutic advances. These findings outline the importance of malignant and non-malignant BM constituents to the pathogenesis and treatment of MF.
摘要
费城阴性骨髓增殖性肿瘤（MPN）是一种恶性骨髓（BM）疾病，通常由单个体细胞突变的造血干细胞引起。最常见的突变基因包括 、 、 和 ，导致 JAK-STAT 信号的持续激活。常见的临床特征包括骨髓增殖、脾肿大和全身症状。本综述涵盖了 MPN 病理学的细胞成分（例如单核细胞、巨核细胞和间充质基质细胞）以及细胞因子和可溶性介质对纤维化（MF）发展的贡献，并强调了最近的治疗进展。这些发现概述了恶性和非恶性 BM 成分对 MF 发病机制和治疗的重要性。
相似文献
1
Remodeling the Bone Marrow Microenvironment - A Proposal for Targeting Pro-inflammatory Contributors in MPN.重塑骨髓微环境——靶向 MPN 中促炎贡献物的建议。
Front Immunol. 2020 Aug 31;11:2093. doi: 10.3389/fimmu.2020.02093. eCollection 2020.
2
Changing concepts of diagnostic criteria of myeloproliferative disorders and the molecular etiology and classification of myeloproliferative neoplasms: from Dameshek 1950 to Vainchenker 2005 and beyond.骨髓增殖性疾病诊断标准的概念变迁以及骨髓增殖性肿瘤的分子病因学与分类：从1950年的达梅谢克到2005年的万琴克尔及以后
Acta Haematol. 2015;133(1):36-51. doi: 10.1159/000358580. Epub 2014 Aug 7.
3
Pathogenesis of myeloproliferative neoplasms.骨髓增殖性肿瘤的发病机制。
Exp Hematol. 2015 Aug;43(8):599-608. doi: 10.1016/j.exphem.2015.06.007. Epub 2015 Jul 21.
4
Mechanism underlying the development of myeloproliferative neoplasms through mutant calreticulin.通过突变钙网蛋白导致骨髓增殖性肿瘤发生的机制。
Cancer Sci. 2020 Aug;111(8):2682-2688. doi: 10.1111/cas.14503. Epub 2020 Jun 27.
5
The Role of Neutrophilic Granulocytes in Philadelphia Chromosome Negative Myeloproliferative Neoplasms.中性粒细胞在费城染色体阴性骨髓增殖性肿瘤中的作用。
Int J Mol Sci. 2021 Sep 3;22(17):9555. doi: 10.3390/ijms22179555.
6
Activation of JAK/STAT Signaling in Megakaryocytes Sustains Myeloproliferation .巨核细胞中 JAK/STAT 信号的激活维持骨髓增殖。
Clin Cancer Res. 2019 Oct 1;25(19):5901-5912. doi: 10.1158/1078-0432.CCR-18-4089. Epub 2019 Jun 19.
7
Effects of JAK1/2 inhibition on bone marrow stromal cells of myeloproliferative neoplasm (MPN) patients and healthy individuals.JAK1/2 抑制对骨髓基质细胞的影响，包括骨髓增生性肿瘤（MPN）患者和健康个体。
Eur J Haematol. 2018 Jul;101(1):57-67. doi: 10.1111/ejh.13079. Epub 2018 Apr 30.
8
Heterogeneity in myeloproliferative neoplasms: Causes and consequences.骨髓增殖性肿瘤中的异质性：原因与后果
Adv Biol Regul. 2019 Jan;71:55-68. doi: 10.1016/j.jbior.2018.11.007. Epub 2018 Nov 22.
9
Myeloproliferative neoplasm stem cells.骨髓增殖性肿瘤干细胞
Blood. 2017 Mar 23;129(12):1607-1616. doi: 10.1182/blood-2016-10-696005. Epub 2017 Feb 3.
10
Unfolding the Role of Calreticulin in Myeloproliferative Neoplasm Pathogenesis. unfolded the role of calreticulin in myeloproliferative neoplasm pathogenesis.
Clin Cancer Res. 2019 May 15;25(10):2956-2962. doi: 10.1158/1078-0432.CCR-18-3777. Epub 2019 Jan 17.
引用本文的文献
1
USP5 inhibition via bone marrow-targeted engineered exosomes for myeloproliferative neoplasms therapy.通过骨髓靶向工程外泌体抑制USP5用于骨髓增殖性肿瘤治疗
J Nanobiotechnology. 2025 Jul 11;23(1):501. doi: 10.1186/s12951-025-03588-4.
2
Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations.塑造骨髓增殖性肿瘤治疗的未来：基于免疫的策略与靶向创新
Cancers (Basel). 2024 Dec 8;16(23):4113. doi: 10.3390/cancers16234113.
3
Elevated levels of damage-associated molecular patterns HMGB1 and S100A8/A9 coupled with toll-like receptor-triggered monocyte activation are associated with inflammation in patients with myelofibrosis.高浓度的损伤相关分子模式 HMGB1 和 S100A8/A9 与 Toll 样受体触发的单核细胞激活相关，与骨髓纤维化患者的炎症有关。
Front Immunol. 2024 Sep 25;15:1365015. doi: 10.3389/fimmu.2024.1365015. eCollection 2024.
4
Oncogenic Calreticulin Induces Immune Escape by Stimulating TGFβ Expression and Regulatory T-cell Expansion in the Bone Marrow Microenvironment.致癌性钙网蛋白通过刺激骨髓微环境中转化生长因子β的表达和调节性T细胞的扩增诱导免疫逃逸。
Cancer Res. 2024 Sep 16;84(18):2985-3003. doi: 10.1158/0008-5472.CAN-23-3553.
5
Non-canonical Hedgehog signaling mediates profibrotic hematopoiesis-stroma crosstalk in myeloproliferative neoplasms.非经典 Hedgehog 信号通路介导骨髓增殖性肿瘤中促纤维化的造血-基质细胞串扰。
Cell Rep. 2024 Jan 23;43(1):113608. doi: 10.1016/j.celrep.2023.113608. Epub 2023 Dec 20.
6
High cell-free DNA is associated with disease progression, inflammasome activation and elevated levels of inflammasome-related cytokine IL-18 in patients with myelofibrosis.高细胞游离 DNA 与疾病进展、炎症小体激活以及骨髓纤维化患者中炎症小体相关细胞因子 IL-18 水平升高相关。
Front Immunol. 2023 Nov 16;14:1161832. doi: 10.3389/fimmu.2023.1161832. eCollection 2023.
7
Quantitative interpretation of bone marrow biopsies in MPN-What's the point in a molecular age?骨髓活检在 MPN 中的定量解读——在分子时代有何意义？
Br J Haematol. 2023 Nov;203(4):523-535. doi: 10.1111/bjh.19154. Epub 2023 Oct 19.
8
Revisiting Circulating Extracellular Matrix Fragments as Disease Markers in Myelofibrosis and Related Neoplasms.重新审视循环细胞外基质片段作为骨髓纤维化及相关肿瘤的疾病标志物
Cancers (Basel). 2023 Aug 29;15(17):4323. doi: 10.3390/cancers15174323.
9
Tracking fibrosis in myeloproliferative neoplasms by CCR2 expression on CD34 cells.通过CD34细胞上CCR2的表达追踪骨髓增殖性肿瘤中的纤维化
Front Oncol. 2022 Aug 22;12:980379. doi: 10.3389/fonc.2022.980379. eCollection 2022.
10
Mechanical checkpoint regulates monocyte differentiation in fibrotic niches.机械检查点调节成纤维细胞病灶中单核细胞的分化。
Nat Mater. 2022 Aug;21(8):939-950. doi: 10.1038/s41563-022-01293-3. Epub 2022 Jul 11.
本文引用的文献
1
Longitudinal Cytokine Profiling Identifies GRO-α and EGF as Potential Biomarkers of Disease Progression in Essential Thrombocythemia.纵向细胞因子分析确定GRO-α和表皮生长因子为原发性血小板增多症疾病进展的潜在生物标志物。
Hemasphere. 2020 May 21;4(3):e371. doi: 10.1097/HS9.0000000000000371. eCollection 2020 Jun.
2
Role of inflammation in the biology of myeloproliferative neoplasms.炎症在骨髓增殖性肿瘤生物学中的作用。
Blood Rev. 2020 Jul;42:100711. doi: 10.1016/j.blre.2020.100711. Epub 2020 May 30.
3
Single-Cell Analyses Reveal Megakaryocyte-Biased Hematopoiesis in Myelofibrosis and Identify Mutant Clone-Specific Targets.单细胞分析揭示骨髓纤维化中巨核细胞偏向性造血并鉴定突变克隆特异性靶点。
Mol Cell. 2020 May 7;78(3):477-492.e8. doi: 10.1016/j.molcel.2020.04.008.
4
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study.聚乙二醇干扰素α-2b对比真性红细胞增多症标准疗法（PROUD-PV和CONTINUATION-PV）：一项随机、非劣效性3期试验及其扩展研究。
Lancet Haematol. 2020 Mar;7(3):e196-e208. doi: 10.1016/S2352-3026(19)30236-4. Epub 2020 Jan 31.
5
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone.抑制赖氨酸特异性去甲基化酶1（LSD1）可通过选择性靶向疾病克隆来延长骨髓增殖性肿瘤（MPN）小鼠模型的生存期。
Hemasphere. 2018 Jun 8;2(3):e54. doi: 10.1097/HS9.0000000000000054. eCollection 2018 Jun.
6
Description of a knock-in mouse model of JAK2V617F MPN emerging from a minority of mutated hematopoietic stem cells.描述了一种 JAK2V617F MPN 的敲入小鼠模型，该模型源自少数突变造血干细胞。
Blood. 2019 Dec 26;134(26):2383-2387. doi: 10.1182/blood.2019001163.
7
Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice.新型赖氨酰氧化酶抑制剂可减轻小鼠原发性骨髓纤维化的特征。
Int J Hematol. 2019 Dec;110(6):699-708. doi: 10.1007/s12185-019-02751-6. Epub 2019 Oct 21.
8
Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes.原发性骨髓纤维化骨髓来源的 CD14+/CD34- 单核细胞在免疫缺陷小鼠中诱导骨髓纤维化样表型，并产生巨核细胞。
PLoS One. 2019 Sep 30;14(9):e0222912. doi: 10.1371/journal.pone.0222912. eCollection 2019.
9
The Molecular Genetics of Myeloproliferative Neoplasms.骨髓增殖性肿瘤的分子遗传学。
Cold Spring Harb Perspect Med. 2020 Feb 3;10(2):a034876. doi: 10.1101/cshperspect.a034876.
10
Somatic mutations and cell identity linked by Genotyping of Transcriptomes.通过转录组的基因分型将体细胞突变与细胞身份联系起来。
Nature. 2019 Jul;571(7765):355-360. doi: 10.1038/s41586-019-1367-0. Epub 2019 Jul 3.
Zotero 插件